Research graph
References from Establishment and Application of a Quantitative Lipemia Index as a Novel Indicator for Assessing Lipemic Interference in Clinical Chemistry. Local targets link to admitted publications; unresolved targets remain external evidence.
Evaluating Interference Caused by Lipemia
10.1373/clinchem.2004.038075 · 2004 · External reference
Serum Indices: Managing Assay Interference
10.1177/0004563216643557 · 2016 · External reference
Lipemia Interferences in Routine Clinical Biochemical Tests
10.11613/bm.2011.025 · 2011 · External reference
Unreliability of Triglyceride Measurement to Predict Turbidity Induced Interference
10.1136/jcp.56.11.861 · 2003 · External reference
Relationship Between Turbidity of Lipid Vesicle Suspensions and Particle Size
10.1006/abio.2001.5012 · 2001 · External reference
Call for More Transparency in Manufacturers Declarations on Serum Indices: On Behalf of the Working Group for Preanalytical Phase (WG‐PRE), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
10.1016/j.cca.2018.03.043 · 2018 · External reference
Assay‐Specific Differences in Lipemic Interference in Native and Intralipid‐Supplemented Samples
10.1373/clinchem.2004.040154 · 2004 · External reference
Lipemia: Causes, Interference Mechanisms, Detection and Management
10.11613/bm.2014.008 · 2014 · External reference
Unresolved reference
2020 · External reference
Frozen Serum Sample Pool Should not Be Used as Internal Quality Assess Ment for Lipemia (L) Index
10.1515/cclm-2022-0647 · 2022 · External reference
Unresolved reference
External reference
Unresolved reference
2012 · External reference
Unresolved reference
External reference
Unresolved reference
2014 · External reference
Unresolved reference
2022 · External reference
Unresolved reference
2005 · External reference
Unresolved reference
2010 · External reference
Unresolved reference
2002 · External reference
Comparing Correlated Correlation Coefficients
10.1037/0033-2909.111.1.172 · 1992 · External reference
Partly Nonparametric Approach for Determining the Limit of Detection
10.1373/clinchem.2003.029983 · 2004 · External reference
The Lipemia Index: An Underutilized Tool to Detect Monoclonal Proteins
10.1373/jalm.2018.028456 · 2019 · External reference
Establishing Hemolysis and Lipemia Acceptance Thresholds for Clinical Chemistry Tests
10.1016/j.cca.2020.08.004 · 2020 · External reference
Assessment of the Lipemia Index Determined by the Atellica CH 930 Analyzer for the Detection of Monoclonal Immunoglobulins
10.1515/cclm-2023-0872 · 2024 · External reference
Comparison of Triglyceride Concentration With Lipemic Index in Disorders of Triglyceride and Glycerol Metabolism
10.1515/cclm.2006.040 · 2006 · External reference
A Case Report of Pseudo‐Hypertriglyceridemia
10.1684/abc.2021.1674 · 2021 · External reference
Determination of Lipemia Acceptance Thresholds for 31 Immunoassay Analytes
10.1016/j.cca.2023.117508 · 2023 · External reference
Methods to Reduce Lipemic Interference in Clinical Chemistry Tests: A Systematic Review and Recommendations
2022 · External reference
Managing Hemolyzed Samples in Clinical Laboratories
10.1080/10408363.2019.1664391 · 2020 · External reference
Precision, Accuracy, Cross Reactivity and Comparability of Serum Indices Measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 Clinical Chemistry Analyzers
10.1515/cclm-2017-0889 · 2018 · External reference
Lipemia Index and Screening for Hyperlipidemia ‐ A Diagnostic Opportunity?
10.1016/j.cca.2019.10.024 · 2020 · External reference
